SCHEMBL5485588

SCHEMBL5485588

NC(=O)CNC(=O)OCc1ccccc1.NC(=O)CNC(=O)OCc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
HTT P42858 1/20 0.58
PLAU P00749 1/20 0.57
ALDH1A1 P00352 1/20 0.56
CA12 O43570 2/20 0.55
CA1 P00915 2/20 0.55
CA2 P00918 2/20 0.55
CA9 Q16790 2/20 0.55
CTSL P07711 1/20 0.55
CTSB P07858 1/20 0.55
CTSS P25774 1/20 0.55
CTSK P43235 1/20 0.55
TP53 P04637 1/20 0.54
MAPT P10636 1/20 0.54
PRSS1 P07477 1/20 0.51
TPSAB1 Q15661 1/20 0.51
TPSD1 Q9BZJ3 1/20 0.51
TPSG1 Q9NRR2 1/20 0.51
TSHR P16473 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2820683 1.00 LMNA (0.61) LMNASMN1; SMN2HTTPLAUALDH1A1
Acetic Acid SCHEMBL8324881 0.95 LMNA (0.56) LMNASMN1; SMN2HTTPLAUALDH1A1
SCHEMBL8156969 0.94 ALDH1A1 (0.58) LMNASMN1; SMN2HTTPLAUALDH1A1
SCHEMBL16258192 0.94 ALDH1A1 (0.58) LMNASMN1; SMN2HTTPLAUALDH1A1
SCHEMBL3254019 0.87 LMNA (0.58) LMNASMN1; SMN2HTTPLAUALDH1A1
SCHEMBL22580054 0.87 LMNA (0.58) LMNASMN1; SMN2HTTPLAUALDH1A1
SCHEMBL21771638 0.87 LMNA (0.62) LMNASMN1; SMN2HTTPLAUALDH1A1
SCHEMBL1337448 0.87 LMNA (0.58) LMNASMN1; SMN2HTTPLAUALDH1A1
SCHEMBL11783251 0.86 HTT (0.66) LMNASMN1; SMN2HTTPLAUALDH1A1
SCHEMBL6741072 0.86 LMNA (0.65) LMNASMN1; SMN2HTTALDH1A1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1056446-A1 ANTICONVULSANT DRUGS AND PHARMACEUTICAL COMPOSITIONS THEREOF YISSUM RESEARCH AND DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2000-12-06 EP claimed
US-6028102-A Anticonvulsant drugs and pharmaceutical compositions thereof YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM 2000-02-22 US claimed
WO-1999043309-A2 ANTICONVULSANT DRUGS AND PHARMACEUTICAL COMPOSITIONS THEREOF YISSUM RESEARCH DEVELOPMENT COMPANY (IL) 1999-09-02 WO claimed
EP-2210598-B1 Anticonvulsant amino acids for the treatment of pain RES CORP TECHNOLOGIES INC (US) 2013-09-18 EP disclosed
EP-1486205-B1 Use of anticonvulsant aminoacids for the treatment of migraine RES CORP TECHNOLOGIES INC (US) 2007-10-17 EP disclosed
EP-1486206-B1 Uses of anticonvulsant aminoacids for the treatment of bipolar disorders RES CORP TECHNOLOGIES INC (US) 2007-10-17 EP disclosed
EP-1365787-B1 USE OF AMINO ACID ANTICONVULSANTS FOR TREATMENT OF PAIN RES CORP TECHNOLOGIES INC (US) 2007-03-21 EP disclosed
EP-1056446-A1 ANTICONVULSANT DRUGS AND PHARMACEUTICAL COMPOSITIONS THEREOF YISSUM RESEARCH AND DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2000-12-06 EP disclosed
EP-1056446-A1 ANTICONVULSANT DRUGS AND PHARMACEUTICAL COMPOSITIONS THEREOF YISSUM RESEARCH AND DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2000-12-06 EP disclosed
US-6028102-A Anticonvulsant drugs and pharmaceutical compositions thereof YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM 2000-02-22 US disclosed
US-6028102-A Anticonvulsant drugs and pharmaceutical compositions thereof YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM 2000-02-22 US disclosed
WO-1999043309-A3 ANTICONVULSANT DRUGS AND PHARMACEUTICAL COMPOSITIONS THEREOF YISSUM RES DEV CO (IL) 2000-01-13 WO disclosed
WO-1999043309-A2 ANTICONVULSANT DRUGS AND PHARMACEUTICAL COMPOSITIONS THEREOF YISSUM RESEARCH DEVELOPMENT COMPANY (IL) 1999-09-02 WO disclosed
WO-1999043309-A2 ANTICONVULSANT DRUGS AND PHARMACEUTICAL COMPOSITIONS THEREOF YISSUM RESEARCH DEVELOPMENT COMPANY (IL) 1999-09-02 WO disclosed